- Open
- 202.00
- High
- 206.44
- Low
- 199.68
- Close
- 202.01
- Change
- -2.00 (-0.99%)
- Volume
- 539,273
| 7 Oct 2026 | 07:10:02 | Holding(s) in Company |
| 7 Oct 2026 | 07:00:04 | Block Listing Return |
| 6 Oct 2026 | 07:00:01 | PDMR Shareholding/SIP and Total Voting Rights |
| 24 Sept 2026 | 07:00:08 | Diaceutics and Syndax expand Relay partnership |
| 22 Sept 2026 | 07:00:04 | Interim Results - six months ended 30 June 2026 |
| 10 Jul 2026 | Annual Report and Accounts (to 2025-12-31) |
Diaceutics plc provides technology and solutions to the pharmaceutical and biotech industries, focusing on the commercialization of precision medicine diagnostics. The company offers data analytics, scientific, and advisory services through its platform, DXRX - The Diagnostics Network®. Diaceutics works with global pharmaceutical companies to enhance diagnostic pathways, ensuring that patients receive appropriate therapies based on biomarker testing. Its customer base includes many of the top pharmaceutical firms, and it operates in various international markets.
| 7 Oct 2026 | 07:10:02 | Holding(s) in Company |
| 7 Oct 2026 | 07:00:04 | Block Listing Return |
| 6 Oct 2026 | 07:00:01 | PDMR Shareholding/SIP and Total Voting Rights |
| 24 Sept 2026 | 07:00:08 | Diaceutics and Syndax expand Relay partnership |
| 22 Sept 2026 | 07:00:04 | Interim Results - six months ended 30 June 2026 |
| 10 Jul 2026 | Annual Report and Accounts (to 2025-12-31) |
Diaceutics plc provides technology and solutions to the pharmaceutical and biotech industries, focusing on the commercialization of precision medicine diagnostics. The company offers data analytics, scientific, and advisory services through its platform, DXRX - The Diagnostics Network®. Diaceutics works with global pharmaceutical companies to enhance diagnostic pathways, ensuring that patients receive appropriate therapies based on biomarker testing. Its customer base includes many of the top pharmaceutical firms, and it operates in various international markets.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £301m | -0.4% | |
| £284m | -0.1% | |
DXRXDiaceutics plc | £172m | +0.2% |
| £28m | — | |
| £25m | -0.7% | |
| £18m | -0.3% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £301m | -0.4% | |
| £284m | -0.1% | |
DXRXDiaceutics plc | £172m | +0.2% |
| £28m | — | |
| £25m | -0.7% | |
| £18m | -0.3% |
